These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 6198428)

  • 1. A reexamination of the role of LYT-2-positive T cells in murine skin graft rejection.
    LeFrancois L; Bevan MJ
    J Exp Med; 1984 Jan; 159(1):57-67. PubMed ID: 6198428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of leucyl-leucine methyl ester-sensitive cytotoxic cells in skin allograft rejection.
    Thiele DL; Geissler GH; Williams FH; Lipsky PE
    Transplantation; 1992 Jun; 53(6):1334-40. PubMed ID: 1604489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell subsets in the immune rejection of murine heterotopic corneal allografts.
    Matoba AY; Peeler JS; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1244-54. PubMed ID: 2942516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells.
    Greenberg PD; Kern DE; Cheever MA
    J Exp Med; 1985 May; 161(5):1122-34. PubMed ID: 3921652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.
    Fujiwara H; Fukuzawa M; Yoshioka T; Nakajima H; Hamaoka T
    J Immunol; 1984 Sep; 133(3):1671-6. PubMed ID: 6205091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow-derived T lymphocytes responsible for allograft rejection.
    Senjanović M; Marusić M
    Cell Immunol; 1984 Aug; 87(1):225-30. PubMed ID: 6204774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4-CD8- T cell receptor alpha beta T cells: generation of an in vitro major histocompatibility complex class I specific cytotoxic T lymphocyte response and allogeneic tumor rejection.
    Mieno M; Suto R; Obata Y; Udono H; Takahashi T; Shiku H; Nakayama E
    J Exp Med; 1991 Jul; 174(1):193-201. PubMed ID: 1905338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of alloimmune cytotoxic T lymphocyte (CTL) generation by depletion of NK cells and restoration by interferon and/or interleukin 2.
    Suzuki R; Suzuki S; Ebina N; Kumagai K
    J Immunol; 1985 Apr; 134(4):2139-48. PubMed ID: 2579129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow transplantation across major histocompatability barriers in mice. III. Treatment of donor grafts with monoclonal antibodies directed against Lyt determinants.
    Vallera DA; Soderling CC; Kersey JH
    J Immunol; 1982 Feb; 128(2):871-5. PubMed ID: 6172513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific and nonspecific resistance to local graft-versus-host reaction in F1 hybrids pretreated intravenously with parent-strain spleen cells. I. Two distinct mechanisms.
    Kosmatopoulos K; Scott-Algara D; Cabannes J; Orbach-Arbouys S
    Transplantation; 1987 Aug; 44(2):267-73. PubMed ID: 2888224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rejection of skin grafts and generation of cytotoxic T cells by mice depleted of L3T4+ cells.
    Woodcock J; Wofsy D; Eriksson E; Scott JH; Seaman WE
    Transplantation; 1986 Dec; 42(6):636-42. PubMed ID: 2947360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H-40, an antigen controlled by an Igh-linked gene and recognized by cytotoxic T lymphocytes. II. Recognition of H-40 as a tumor antigen in leukemic animals.
    Henderson LA; Ciavarra R; Riblet R; Forman J
    J Immunol; 1984 Nov; 133(5):2778-85. PubMed ID: 6434638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal analysis of cytolytic T lymphocyte-mediated lysis of target cells with inducible antigen expression: correlation between antigen density and requirement for Lyt-2/3 function.
    Shimonkevitz R; Luescher B; Cerottini JC; MacDonald HR
    J Immunol; 1985 Aug; 135(2):892-9. PubMed ID: 2409156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of anti-Lyt-2 and anti-L3T4 monoclonal antibodies on the function of cytotoxic T lymphocyte/helper T lymphocyte hybrid T cell clones.
    Havran WL; Fitch FW
    J Immunol; 1988 Sep; 141(6):1808-12. PubMed ID: 2459190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of hyperacute rejection of skin allografts by CD8+ lymphocytes.
    Yoshimura R; Chargui J; Aitouche A; Veyron P; Touraine JL
    Transplantation; 2000 Apr; 69(7):1452-7. PubMed ID: 10798770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of lymphokine-activated killer cells to prevent bone marrow graft rejection and lethal graft-vs-host disease.
    Azuma E; Yamamoto H; Kaplan J
    J Immunol; 1989 Sep; 143(5):1524-9. PubMed ID: 2668409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific inhibition of hybrid resistance in F1 hybrid mice pretreated with parent strain spleen cells. I. Induction of a nylon-adherent, Thy-1+Lyt-1+2- suppressor cell.
    Kosmatopoulos K; Orbach-Arbouys S
    J Immunol; 1987 Feb; 138(3):704-12. PubMed ID: 2879865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune thyroiditis induced in mice depleted of particular T cell subsets. I. Requirement of Lyt-1 dull L3T4 bright normal T cells for the induction of thyroiditis.
    Sugihara S; Izumi Y; Yoshioka T; Yagi H; Tsujimura T; Tarutani O; Kohno Y; Murakami S; Hamaoka T; Fujiwara H
    J Immunol; 1988 Jul; 141(1):105-13. PubMed ID: 2967864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for differentiation of NK1+ cells into cytotoxic T cells during acute rejection of allogeneic bone marrow grafts.
    Dennert G; Knobloch C; Sugawara S; Yankelevich B
    Immunogenetics; 1990; 31(3):161-8. PubMed ID: 2108082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. I. L3T4+ cells can either augment or retard GVHD elicited by Lyt-2+ cells in class I different hosts.
    Sprent J; Schaefer M; Gao EK; Korngold R
    J Exp Med; 1988 Feb; 167(2):556-69. PubMed ID: 2964497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.